idarubicin has been researched along with morpholinoanthracycline mx2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariyoshi, Y; Ogawa, M | 1 |
| Hu, XF; Kantharidis, P; Parkin, JD; Rischin, D; Slater, A; Zalcberg, J | 1 |
1 review(s) available for idarubicin and morpholinoanthracycline mx2
| Article | Year |
|---|---|
[New anthracyclines].
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms | 1993 |
1 trial(s) available for idarubicin and morpholinoanthracycline mx2
| Article | Year |
|---|---|
[New anthracyclines].
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms | 1993 |
1 other study(ies) available for idarubicin and morpholinoanthracycline mx2
| Article | Year |
|---|---|
Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
Topics: Anthracyclines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carubicin; Cell Survival; Clone Cells; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Kinetics; Leukemia, T-Cell; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |